`Remipi; data; 1222;123:115
`15/349,778 w GM: 1574
`
`Application Number
`15349778
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`
`
`
`
`
`
`Filing Date
`2016-11-11
`First Named Inventor
`Peter SAZANI
`
`Art Unit
`|1574
`
`
`
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number
`|AVN-009DVCN6
`
`orcos, Paul A., "Gene switching: analyzing a broad range of mutations using steric block antisense Oligonucleotides,"
`ethods in Enzymology, Vol. 313:174-189 (1999)
`
`OULTON, H.M., "Compound and Method for Treating Myotonic Dystrophy," US. Application No. 12/493,140, 82
`ages, filed June 26, 2009
`
`OULTON, Hong M. et al., "Morpholinos and their peptide conjugates: Therapeutic promise and challenge for
`I uchenne muscular dystrophy," Biochimica et Biophysica Acta, Vol. 1798:2296—2303 (2010)
`
`untoni F, et al., "Dystrophin and mutations: one gene, several proteins, multiple phenotypes," Lancet Neurol.
`'003;2:731—40_
`
`UNTONI, Francesco et at, "128th ENMC lntemational Workshop on 'Preclinical optimization and Phase IIII Clinical
`rials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy' 22—24 October 2004, Naarden, The
`etherlands," Neuromuscular Disorders, Vol. 15:450—457 (2005) (Exhibit Number 2025 filed in interferences 106008,
`06013, 106007 on November 18, 2014)
`
`UNTONI, Francesco et at, "149th ENMC lntemational Workshop and 1st TREAT-N MD Workshop on: 'Planning
`'hase II” Clinical trials using Systemically Delivered Antisense Oligonucleotides in Duchenne Muscular Dystrophy,
`euromuscular Disorders, Vol. 18:268—275 (2008)
`
`ELSON, David L. et al., "Nucleotides and Nucleic Acids," Lehninger Principles of Biochemistry, 3rd Edition, Chapter
`0, pages 325-328 and glossary page 6—1 1, Worth Publishers, New York (2000)
`
`guyen TM, et. A|., "Use of Epitope libraries to identify exon-specific monoclonal antibodies for characterization of
`ltered dystrophins in muscular dystrophy," Am J Hum Genet 1993;52:1057—66.
`
`oberbauer, "Renal uptake of an 18—mer phosphorothioate oligonucleotide," Kidney lnt'l, Vol. 48, pp. 1226—1232 (1995),
`xhibit Number 1191 filed in Interferences 106,007 and 106,008 on February 17, 2015.
`
`oligonucleotide Cleavage and Deprotection Laboratory Notebook Entry, Pages 1, Exhibit Number 1138 filed in
`nterferences 106,007 and 106,008 on February 16, 2015.
`
`oligonucleotide diagrams, 5 pages (Exhibit Number 1053 filed in interferences 106008, 106007 on November 18,
`
`EFS Web 2.1.17
`
`ALL REFERENCES CONSIDERED EXCEFT WHERE LINED THROUGH.
`
`/JPM/
`
`